Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies

Minerva Cardioangiologica

Volumn 57, Issue 4, 2009, Pages 511-520

  Wassmuth, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiomyopathies; Edema; Fibrosis; Magnetic resonance imaging; Myocarditis

Indexed keywords

ANTHRACYCLINE; CONTRAST MEDIUM; GADOLINIUM; GROWTH HORMONE;

AMYLOIDOSIS; CARDIAC PATIENT; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE IMAGING; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FABRY DISEASE; FUNCTIONAL ASSESSMENT; HEART ARRHYTHMIA; HEART ATRIUM; HEART EDEMA; HEART INFARCTION; HEART INJURY; HEART MASSAGE; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SIZE; HEMOSIDEROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MUSCULAR DYSTROPHY; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TAKOTSUBO CARDIOMYOPATHY; VIRUS MYOCARDITIS;

AMYLOIDOSIS; CARDIOMYOPATHIES; CHURG-STRAUSS SYNDROME; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; EDEMA; FABRY DISEASE; FEASIBILITY STUDIES; FEMALE; FIBROSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; MYOCARDITIS; SYSTOLE;

EID: 71049192778     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC et al. ACCF/ACR/SCCT/SCMR/ASNC/ NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography
2. Ledneva E, Karie S, Launay-Vacher V, Janus N, Deray G. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency. Radiology 2009;250:618-628
3. Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 2005;26:607-616
4. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005;7:775-782 (Pubitemid 41770055)
5. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006;8:417-426
6. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006;47:2357-2363
7. Hudsmith LE, Cheng AS, Tyler DJ, Shirodaria C, Lee J, Petersen SE et al. Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging. J Cardiovasc Magn Reson 2007;9:673-679 (Pubitemid 46956902)
8. Anderson JL, Home BD, Pennell DJ. Atrial dimensions in health and left ventricular disease using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005;7:671-675 (Pubitemid 41176833)
9. Tsao CW, Josephson ME, Hauser TH, O'Halloran TD, Agarwal A, Manning WJ et al. Accuracy of electrocardiographic criteria for atrial enlargement: validation with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:7.
10. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003; 5:505-514
11. Bohl S, Wassmuth R, Abdel-Aty H, Rudolph A, Messroghli D, Dietz R et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 2008;24:597-607.
12. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007;26:452-459. (Pubitemid 350194566)
13. Zagrosek A, Wassmuth R, Abdel-Aty H, Rudolph A, Dietz R, Schulz-Menger J. Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis - a CMR study. J Cardiovasc Magn Reson 2008;10:19.
14. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865-1870.
15. Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2009;53:1194-1201
16. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411-2416 (Pubitemid 38679560)
17. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med 2007;57: 891-897 (Pubitemid 46709409)
18. Aletras AH, Kellman P, Derbyshire JA, Arai AE. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med 2008;59:229-235
19. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1809 (Pubitemid 28213624)
20. Imazio M, Trinchero R. Myopericarditis: Etiology, management, and prognosis. Int J Cardiol 2008;127:17-26.
21. Danti M, Sbarbati S, Alsadi N, Di Filippo A, Gangitano G, Giglio L et al. Cardiac magnetic resonance imaging: diagnostic value and utility in the follow-up of patients with acute myocarditis mimicking myocardial infarction. Radiol Med 2009;114:229-238
22. Zagrosek A, Abdel-Aty H, Boyé P, Wassmuth R, Messroghli D, Utz W et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009;2:131-138
23. Gutberlet M, Spors B, Thoma T, Bertram H, Denecke T, Felix R et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008;246:401-409
24. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-1258 (Pubitemid 38379570)
25. Mahrholdt H, Wagner A, Deluigi CC, Meinhardt G, Athanasiadis A, Vogelsberg H et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-1590 (Pubitemid 44547428)
26. Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-1822 (Pubitemid 40779862)
27. Cooper LT, Jr. Myocarditis. N Engl J Med 2009;360: 1526-1538
28. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53:1475-1487
29. Wassmuth R, Lentzsch S, Erdbruegger U, Schulz-Menger J, Doerken B, Dietz R et al. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. Am Heart J 2001;141: 1007-1013 (Pubitemid 32477014)
30. Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001;13:367-371 (Pubitemid 32173402)
31. Koikkalainen JR, Antila M, Lötjönen JM, Heliö T, Lauerma K, Kivistö SM et al. Early familial dilated cardiomyopathy: identification with determination of disease state parameter from cine MR image data. Radiology 2008;249:88-96.
32. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hänlein D, Willenbrock R et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998;351:1233-1237 (Pubitemid 28181962)
33. Beer M, Wagner D, Myers J, Sandstede J, Köstler H, Hahn D et al. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy. J Am Coll Cardiol 2008;51:1883-1891 (Pubitemid 351615253)
34. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:H1234-H1242.
35. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-1985 (Pubitemid 44738448)
36. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59
37. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276
38. Romano R, Losi MA, Migliore T, Contaldi C, Parrella LS, Caputi A et al. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging. Minerva Cardioangiol 2008;56:181-187 (Pubitemid 351715204)
39. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008;118: 1541-1549
40. Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48:2518-2523 (Pubitemid 44881223)
41. Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418-2425 (Pubitemid 46717964)
42. Schulz-Menger J, Strohm O, Waigand J, Uhlich F, Dietz R, Friedrich MG. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 2000;101: 1764-1766 (Pubitemid 30213095)
43. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-1567
44. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Büros JL, Gibson CM et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-1374
45. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-218 (Pubitemid 24113523)
46. Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R, Gimeno JR et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-1450 (Pubitemid 35192870)
47. Alfakih K, Plein S, Bloomer T, Jones T, Ridgway J, Sivananthan M. Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging 2003;18: 25-32. (Pubitemid 36791265)
48. Burke AP, Farb A, Tashko G, Virmani R. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 1998;97:1571-1580
49. Bluemke DA, Krupinski EA, Ovitt T, Gear K, Unger E, Axel L et al. MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 2003;99:153-162 (Pubitemid 36736958)
50. Tandri H, Saranathan M, Rodriguez ER, Martinez C, Bomma C, Nasir K et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98-103. (Pubitemid 40052034)
51. Hunold P, Wieneke H, Bruder O, Krueger U, Schlosser T, Erbel R et al. Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy? J Cardiovasc Magn Reson 2005;7:649-655
52. Tandri H, Castillo E, Ferrari VA, Nasir K, Dalal D, Bomma C et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48:2277-2284 (Pubitemid 44855415)
53. Dalal D, Tandri H, Judge DP, Amat N, Macedo R, Jain R et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol 2009;53:1289-1299
54. Pieroni M, Dello Russo A, Marzo F, Pelargonio G, Casella M, Bellocci F et al. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J Am Coll Cardiol 2009;53:681-689
55. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008;52:2175-2187
56. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990;82:507-513
57. Jenni R, Oechslin E, Schneider J, Jost CA, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 2001;86:666-671 (Pubitemid 33086886)
58. Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46: 101-105 (Pubitemid 40905136)
59. Biagini E, Ragni L, Ferlito M, Pasquale F, Lofiego C, Leone O et al. Different types of cardiomyopathy associated with isolated ventricular noncompaction. Am J Cardiol 2006;98:821-824 (Pubitemid 44301022)
60. Alsaileek AA, Syed I, Seward JB, Julsrud P. Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction. J Magn Reson Imaging 2008;27:621-624 (Pubitemid 351354749)
61. Sen-Chowdhry S, McKenna WJ. Left ventricular non- compaction and cardiomyopathy: cause, contributor, or epiphenomenon? Curr Opin Cardiol 2008;23:171-175
62. Eitel I, Behrendt F, Schindler K, Kivelitz D, Gutberlet M, Schuler G et al. Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur Heart J 2008;29:2651-2659
63. Crean A, Greenwood JP, Plein S. Contribution of non- invasive imaging to the diagnosis and follow-up of Takotsubo cardiomyopathy. JACC Cardiovasc Imaging 2009;2:519-521
64. Abdel-Aty H, Cocker M, Friedrich MG. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol 2009;132:291-293
65. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58: 1204-1211
66. Kim JS, Judson MA, Donnino R, Gold M, Cooper LTJr, Prystowsky EN et al. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.
67. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184:249-254 (Pubitemid 40040938)
68. Manins V, Habersberger J, Pfluger H, Taylor AJ. Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis: an Australian single-centre experience. Intern Med J 2008.
69. Shimada T, Shimada K, Sakane T, Ochiai K, Tsukihashi H, Fukui M et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-527
70. Schulz-Menger J, Wassmuth R, Abdel-Aty H et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006;92:399-400. (Pubitemid 43295117)
71. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-1690 (Pubitemid 40704507)
72. Ichinose A, Otani H, Oikawa M, Takase K, Saito H, Shimokawa H et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol 2008;191:862-869
73. He T, Kirk P, Firmin DN, Lam WM, Chu WC, Au WY et al. Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment. J Cardiovasc Magn Reson 2008;10:11.
74. Meloni A, Pepe A, Positano V, Favilli B, Maggio A, Capra M et al. Influence of myocardial fibrosis and blood oxygenation on heart T2* values in thalassemia patients. J Magn Reson Imaging 2009;29:832-837
75. Edwards NC, Ferro CJ, Townend JN, Steeds RP. Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology (Oxford) 2007;46:1208-1209
76. O'Neill SG, Woldman S, Bailliard F, Norman W, McEwan J, Isenberg DA et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2008 [Epub ahead of print].
77. Singh JA, Woodard PK, Dávila-Román VG, Waggoner AD, Gutierrez FR, Zheng J et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus ery3 thematosus: a preliminary report. Lupus 2005;14: 137-144 (Pubitemid 40327664)
78. Abdel-Aty H, Siegle N, Natusch A, Gromnica-Ihle E, Wassmuth R, Dietz R et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008;17:561-567 (Pubitemid 351955432)
79. Wassmuth R, Göbel U, Natusch A, Schneider W, Kettritz R, Dietz R et al. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail 2008;14:856-860
80. Hansch A, Pfeil A, Rzanny R, Neumann T, Kaiser WA. First-pass myocardial perfusion abnormalities in Churg- Strauss Syndrome with cardiac involvement. Int J Cardiovasc Imaging 2009;25:501-510
81. Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 2008;10:50.
82. Guillaume MD, Phoon CK, Chun AJ, Srichai MB. Delayed enhancement cardiac magnetic resonance imaging in a patient with Duchenne muscular dystrophy. Tex Heart Inst J 2008;35:367-368
83. Barison A, Aquaro GD, Passino C, Falorni M, Balbarini A, Lombardi M et al. Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier. J Neurol 2009;256:283-284
84. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 2009;53:1204-1210
85. Zhang W, ten Hove M, Schneider JE, Stuckey DJ, Sebag- Montefiore L, Bia BL et al. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol 2008;45:754-760
86. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51:1022-1030 (Pubitemid 351318125)
87. Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006;92:343-349 (Pubitemid 43295102)
88. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193 (Pubitemid 40139730)
89. Ruberg FL, Appelbaum E, Davidoff R, Ozonoff A, Kissinger KV, Harrigan C et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 2009;103:544-549
90. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008;10:54.
91. Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24: 2151-2155
92. Rutz AK, Juli CF, Ryf S, Widmer U, Kozerke S, Eckhardt BP et al. Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging. J Cardiovasc Magn Reson 2007;9:891-898 (Pubitemid 350232933)
93. Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Stork S et al. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation 2009;119:524-529